PTIX
Protagenic Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.75
−1.64%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
316.9%
Return on equity
261.8%
Return on assets
-247.0%
Return on invested capital
0.00x
Asset turnover
-$2.6M
Cash from operations
$0.31
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026